Diagnostic Methods for Achalasia
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is the muscle layer biopsy during per-oral endoscopic myotomy (POEM) safe for humans?
How is the esophageal muscle biopsy treatment for achalasia different from other treatments?
The esophageal muscle biopsy treatment for achalasia is unique because it involves directly sampling the muscle layer of the esophagus, which is not typically done in routine procedures. This approach can help identify specific cellular changes, like eosinophilic infiltration, that are not detectable with standard surface biopsies, potentially offering more precise diagnostic information.16789
What is the purpose of this trial?
This trial uses a new technology to map the lower esophageal sphincter in patients with achalasia. It helps doctors understand if the problem is due to muscle stiffness or nerve issues, allowing for earlier and better treatment. EsoFLIP is a new technology used for esophageal dilation in achalasia.
Research Team
Anand Jain, MD
Principal Investigator
Emory University
Eligibility Criteria
Adults over 18 with achalasia or esophageal motility disorders, who are undergoing specific treatments like Heller myotomy or per oral endoscopic myotomy. They must have been evaluated at Emory facilities and not be pregnant, imprisoned, cognitively impaired without consent ability, have severe cardiac issues, respiratory diseases, urinary retention problems, glaucoma, myasthenia gravis or poor kidney function.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pharmacologic Challenge
Measurement of esophageal response to atropine using functional lumen imaging probe (FLIP)
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Atropine challenge
- Esophageal muscle biopsy
Esophageal muscle biopsy is already approved in United States, European Union for the following indications:
- Diagnosis of achalasia
- Evaluation of esophageal motility disorders
- Diagnosis of achalasia
- Evaluation of esophageal motility disorders
- Investigation of eosinophilic esophagitis
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator